And for some patients who are pre-diabetic or have other risk factors, reducing their risk of serious health concerns is priceless
2024;DOI:10.1002/alz.14313.
Sources Andrew Huberman on Protein Myths, Peptides, and the Science of Feeling Better goop New Weight-Loss Shot Appears to Outperform Other Obesity Drugs on Market The Guardian Lillys Phase 2 Retatrutide Results Published in The New England Journal of Medicine Eli Lilly Retatrutide for Obesity: A Phase 2 Trial The New England Journal of Medicine FDAs Concerns With Unapproved GLP-1 Drugs Used for Weight Loss U.S
Serious but Rare Side Effects In rare cases, metformin can cause a serious side effect called lactic acidosis, which requires immediate medical attention
See why Eden includes inositol
On the flip side, digital health has the potential to scale low-cost, effective treatments by combining GLP-1 prescribing with tools that promote adherence and drive meaningful behavior change